Photodynamic therapy in dermatology beyond non-melanoma cancer: An update

Photodiagnosis Photodyn Ther. 2017 Sep:19:140-152. doi: 10.1016/j.pdpdt.2017.06.010. Epub 2017 Jun 21.

Abstract

Photodynamic therapy (PDT) employs a photosensitizer (PS) and visible light in the presence of oxygen, leading to production of cytotoxic reactive oxygen species, which can damage the cellular organelles and cause cell death. In dermatology, PDT has usually taken the form of topical application of a precursor in the heme biosynthesis pathway, called 5-aminolevulinic acid (or its methyl ester), so that an active PS, protoporphyrin IX accumulates in the skin. As PDT enhances dermal remodeling and resolves chronic inflamation, it has been used to treat cutaneous disorders include actinic keratoses, acne, viral warts, skin rejuvenation, psoriasis, localized scleroderma, some non-melanoma skin cancers and port-wine stains. Efforts are still needed to mitigate the side effects (principally pain) and improve the overall procedure.

Keywords: Cosmetic; Dermatology; Photodynamic therapy.

Publication types

  • Review

MeSH terms

  • Acne Vulgaris / drug therapy
  • Aminolevulinic Acid / pharmacology
  • Aminolevulinic Acid / therapeutic use
  • Collagen / biosynthesis*
  • Humans
  • Photochemotherapy / adverse effects
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / therapeutic use*
  • Port-Wine Stain / drug therapy
  • Procollagen / biosynthesis
  • Protoporphyrins / pharmacology
  • Protoporphyrins / therapeutic use
  • Psoriasis / drug therapy
  • Reactive Oxygen Species / metabolism
  • Rejuvenation / physiology
  • Scleroderma, Localized / drug therapy
  • Skin / drug effects
  • Skin Diseases / drug therapy*
  • Skin Temperature
  • Warts / drug therapy

Substances

  • Photosensitizing Agents
  • Procollagen
  • Protoporphyrins
  • Reactive Oxygen Species
  • Aminolevulinic Acid
  • Collagen
  • protoporphyrin IX